Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company reported a significant increase in net profit for Q1 2025, driven by the high demand for refrigerants, with a year-on-year growth of 161% [1] - The refrigerant market is expected to remain strong, supported by demand from downstream sectors such as air conditioning and automotive [4] - The company is projected to achieve net profits of 41 billion, 53 billion, and 61 billion RMB for the years 2025 to 2027, respectively, indicating a robust growth trajectory [5] Revenue and Profitability - In Q1 2025, the company achieved total revenue of 5.8 billion RMB, a year-on-year increase of 6% [1] - The company's gross profit margin improved to 28.4%, reflecting a year-on-year increase of 13.7 percentage points [3] - The earnings per share (EPS) for 2025 is estimated at 1.52 RMB, with a projected growth in EPS for the following years [5] Market Performance - The average price of refrigerants has increased, with R22, R32, R125, and R134a prices rising by 9%, 13%, 7%, and 11% respectively since the beginning of the year [4] - The company's market capitalization is approximately 68.47 billion RMB, with a target price set at 31.92 RMB [9] Segment Performance - The refrigerant segment saw a year-on-year sales increase of 4%, despite a seasonal decline in Q1 [2] - The fluoropolymer segment faced temporary pressure, with a year-on-year sales decline of 7% [2] - The basic chemical products segment benefited from improved caustic soda prices, leading to a revenue increase of 7% year-on-year [3]

Core Viewpoint - The company reported a significant increase in revenue and net profit for the year 2024, driven by the recovery in the refrigerant market, and maintains a "buy" rating due to positive outlooks for future performance [1][4]. Group 1: Financial Performance - The total revenue for 2024 reached 24.5 billion yuan, representing an 18% year-over-year increase [1]. - The net profit attributable to shareholders was 1.96 billion yuan, with a year-over-year growth of 108%, and a non-recurring profit of 1.90 billion yuan, reflecting a 131% increase [1]. - In Q4 2024, the net profit attributable to shareholders was 700 million yuan, with a year-over-year increase of 257% and a quarter-over-quarter increase of 66% [1]. Group 2: Segment Performance - The refrigerant segment saw a 23% year-over-year increase in external sales volume to 353,000 tons, primarily due to the consolidation of Feiyuan Chemical and rising prices under quota systems, with average prices increasing by 33% to 26,800 yuan per ton [2]. - The fluoropolymer segment experienced an 8% year-over-year increase in sales volume to 46,000 tons, but faced price pressure, with average prices declining by 15% to 38,000 yuan per ton [2]. - The fine fluorochemical segment reported a remarkable 255% year-over-year increase in sales volume to 5,000 tons, with revenue growing by 99% to 280 million yuan [2]. Group 3: Market Outlook - The refrigerant market is expected to continue its upward trend, supported by demand from downstream sectors such as air conditioning and automotive, alongside tight supply conditions for second and third-generation refrigerants [3]. - The company is set to benefit from new projects, including FEP, Juxin cooling liquids, and fourth-generation refrigerants, which are anticipated to enhance integrated and scale advantages [3]. Group 4: Profit Forecast and Valuation - The company has revised its profit forecasts upward, expecting net profits of 4.1 billion yuan, 5.3 billion yuan, and 6.1 billion yuan for 2025-2027, reflecting increases of 8% and 14% for 2025-2026 compared to previous estimates [4]. - The target price for the company is set at 30.4 yuan based on a 20x PE ratio for 2025, up from a previous target of 28.2 yuan [4].